Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services, discusses which payment models have the most potential for succeeding in value-based care.
Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services, discusses which payment models have the most potential for succeeding in value-based care.
What payment models do you think have the most potential for succeeding in value-based care?
I think we’ve all been challenged with all of the different value-based payment models. There’s been a lot of experimentation, which is good. We want to experiment and iterate and see what works. I know that capitation works well. We use a lot of capitation within our organization, both for employed clinicians as well as independent clinicians, and that really moves the funding closer to where the patient is to the clinicians and the patients together. I think that’s a really successful model, but it’s not the only one, and not everyone is ready for capitation.
So, I think the work of accountable care organizations is helpful, if you look at bundled payment, that could be helpful, as well. If you look at the new announcement from CMS regarding primary care, they’re really looking at ways to allow primary care physicians to take some risk for Medicare fee-for-service, which is a great thing. Some folks want choice, so they aren’t doing Medicare Advantage HMO [health maintenance organization]; they’ll do fee-for-service, and that creates a place for us to experiment, as well.
I think there’s a lot of models and I think what we want to do as a nation, locally and nationally, is to continue to iterate, reinvent, and I joke about fail fast. Try it and if it doesn’t work, do something different and keep working on it. I’m not ascribed to any particular model, I think we just have to keep working on them.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More